期刊文献+

非诺贝特与过氧化体增殖物激活型受体α对人肝瘤细胞1型纤溶酶原激活物抑制剂表达的影响 被引量:1

Effects of fenofibrate and peroxisome proliferator-activated receptor α on the expression of plasminogen activator inhibitor type-1 in HepG2 cells
下载PDF
导出
摘要 目的探讨非诺贝特对人肝瘤细胞株(HepG2)细胞1型纤维酶原激活物抑制剂(PAI-1)表达的影响及机制。方法用不同浓度非诺贝特刺激HepG2细胞,采用半定量逆转录聚合酶链反应(RT-PCR)法检测PAI-1mRNA水平,发色底物法检测PAI-1的活性变化。构建4个荧光素酶报告基因质粒,分别由PAI-1启动子序列从-804至+17间不同长度片段驱动,体外转染HepG2细胞,检测荧光素酶的活性。结果非诺贝特能使HepG2细胞PAI-1mRNA表达及蛋白活性显著降低,且呈一定剂量依赖性;还可使PAI-1转录活性显著降低;当转染质粒含有PAI-1启动子序列-636^+17、-449^+17-、276^+17 bp 3个片段时,荧光素酶活性显著增高;共转染过氧化体增殖物激活型受体α(PPARα)表达质粒(PPAR-αpSG5)的细胞在非诺贝特诱导下PAI-1转录活性显著降低。结论非诺贝特可以抑制HepG2细胞PAI-1mRNA表达及其活性,调节PAI-1的基因转录,PPARα参与非诺贝特对PAI-1基因的表达调控。 Objective To investigate the effect and mechanisms of fenofibrate on PAI-1 expression in HepG2 cells. Methods HepG2 cells were exposed to fenofibrate at various concentrations. RT-PCR and ELISA were used to determine the expression of PAI-1. Four lucifemse reporter gene plasmids containing different human PAI-1 gene promoter from - 804 to + 17 were constructed and tmnsfected into HepG2 cells. The transcriptional activity of PAI-1 was demonstrated by the luciferase activity. Results Fenofibrate could remarkably depress PAI-1 mRNA expression and protein activity in a concentration-dependent manner, and depress the level of PAI-1 transcription significantly. When the plasmids containing PAI-1 gene promoter -636 ~ + 17, -449 ~ + 17, -276 ~ + 17 bp were transfected, fenofibrate increased the luciferase activity remarkably. When cotraxtsfected with PPARα-pSG5, fenofibrate could depress the level of PAI-1 transcription further more. Conclusions Fenofibrate could regulate PAI-1 mRNA expression and gene transcription. PPARα was involved in the regulation of PAI-1 gene expression.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2006年第3期194-197,共4页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
基金 国家自然科学基金资助(30470717)
关键词 普鲁脂芬 纤溶酶原激活物抑制物1 过氧化物酶体增殖物激活型受体 基因表达 转染 procctofen plasminogcn activator inhibitor 1 peroxisome proliferators-activated receptors gene expression transfection
  • 相关文献

参考文献10

  • 1William PF. Plasminogen activator inhibitor 1, fibrin, and the vascular response to injury[J] .Trends Cardiovasc Med,2004, 14:196-202.
  • 2陈静,叶平,刘永学,贺艳丽.过氧化物酶体增殖物激活型受体α不同激活物对HepG2细胞1型纤溶酶原激活物抑制剂表达的影响[J].中国临床康复,2005,9(31):112-115. 被引量:1
  • 3Messi MC, Juhan VI. Contribution of PAI 1 in cardiovascular pathology[J] .Arch Mal Coeur Vaiss,2004,97:673-678.
  • 4Barbler O, Torra I, Pineda P. Actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis[J]. American Heart Association Inc, 2002,22 : 717-726.
  • 5Eriksson P, Nilsson L, Karpe F, et al. Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhititor-1 gene implicatcd in the impaired fibrinolysis of hypertriglyceridemia[J]. Arterioscler Thromb Verse Biol, 1998, 18 : 20-26.
  • 6Neurmann FJ, Ott I, Gawaz M, et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction[ J ]. Circulation,1995,92 : 748-755.
  • 7叶平,尚延中,张振菊,任中华,殷忠建,李小鹰.微粒化非诺贝特治疗高脂血症疗效和对凝血纤溶系统的影响[J].中华心血管病杂志,1998,26(6):468-468. 被引量:7
  • 8叶平.过氧化体增殖物激活型受体在控制炎症反应中的作用[J].中国动脉硬化杂志,2002,10(3):260-262. 被引量:2
  • 9Archana M, Ashok C, Sanjeev S. Oxidized omega-3 fatty acids inhibit NF-kB activation via a PPARα-dependent pathway [ J ]. Arterioscler Thromb Vase Biol,2004,24: 1621-1627.
  • 10Bernd RB, Gunter C, Florian G, et al. Plasminogen activator inhibitor 1 : physiological and pathophysiological roles [J]. News Physiol Sci,2002,17:56-61.

二级参考文献34

  • 1[1]Gearing KL, Crickmore A, Gustafsson JA. Structure of the mouse peroxisome proliferator activated receptor α gene. Biochem Biophys Res, 1994, 199: 255-263
  • 2[2]Schoonjans K, Staels B, Auwerx J. The peroxisome proliferator activated receptors (PPARs) and their effect on lipid metabolism and adipocyte differentiation. Biochem Biophys Acta, 1996, 1 302: 93-97
  • 3[3]Upenberg A, Jeannin E, Wahi W, et al. Polarity and specific sequence requirerments of peroxisome proliferator-activated receptor (PPAR)/retinoid X receptor heterodimer binding to DNA. J Biol Chem, 1997, 272: 20 108-111
  • 4[4]Delerive P, Bosscher KD, Besnard S, et al. Peroxisome proliferator-activated receptorαnegatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-κB and AP-1. J Biol Chem, 1999, 274: 32 048
  • 5[5]Wilson MT, Wahli W. Peroxisome proliferator -activated receptor agonists. Curr Opin Chem Biol, 1997, 1: 235
  • 6[6]Max N, Sukhova GK, Collins T, et al. PPAR alpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. Circulation, 1999, 99: 3 125-131
  • 7[7]Neve BP, Corseaux D, Chinetti G, et al. PPAR α agonists inhibit tissue factor expression in human monocytes and macrophages. Circulation, 2001, 103: 207-212
  • 8[8]Staels B, Koening W, Habib A, et al. Activation of human aortic smooth muscle cell is inhibited by PPAR α but not by PPAR γ activators. Nature, 1998, 393: 790
  • 9[9]Madej A, Okopien B, Kowalski J, et al. Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia Ⅱb. Int J Pharmacol Thera, 1998, 36: 345-349
  • 10[10]Delerive P, Gervois P, Fruchart JC, et al. Induction of IκBαexpression as a mechanism contributing to the anti-inflammatory activities of PPAR α activators. J Biol Chem, 2000, 275: 36 703-707

共引文献7

同被引文献12

  • 1曹泽玲,叶平,龙超良,陈凯,李小卫,汪海.吡格列酮对缺血再灌注心肌细胞凋亡影响的实验研究[J].中华心血管病杂志,2005,33(7):648-652. 被引量:23
  • 2曹泽玲,叶平,龙超良,陈凯,李小卫,汪海.吡格列酮对大鼠心脏缺血再灌注损伤的保护作用[J].中国临床药理学与治疗学,2005,10(10):1112-1117. 被引量:15
  • 3杨维,叶平,周新,伍仕敏,盛莉,陈静,韩春光,刘永学.吡格列酮对大鼠肥大心肌细胞炎性细胞因子表达的影响[J].中华老年心脑血管病杂志,2006,8(8):552-555. 被引量:10
  • 4Cao ZL,Ye P,Long CL,et al. Effect of pioglitazone,a peroxisome proliferator-activated receptor 7 agonist, on ischemiareperfusion injury in rats. Pharmacology, 2007,79 : 184-192.
  • 5Irani K. Oxidant signaling in vascular cell growth,death,and survival:a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res, 2000,87 : 179-183.
  • 6Hausenloy DJ, Yellon DM. New directions for protecting the heart against isehemia-reperfusion injury:targeting the reperfusion iniury salvage kinase(RISK) pathway. Cardiovase Res, 2004,61:448-460.
  • 7Hasegawa H, Takano H, Zou Y, et al. Pioglitazone, a peroxisome prollferator-actlvated receptor T activator, ameliorates experimental autolmmune myocarditis by modulating Th1/ Th2 balance. J Mol Cell Cardiol,2005,38:257-265.
  • 8Shi YH, Wang YX. In vitro study of HIF-1 activation and VEGF release by bFGF in the T47D breast cancer cell line under normoxic conditions: involvement of PI3K/AKT and MEK1/ERK pathways. J Pathol, 2005,205 : 530-536.
  • 9Maloyan A, Berchoer L,Semenza GL, et al. HIF-1α targeted pathways are activated by heat acclimation and contribute to acclimation-ischemic cross-tolerance in the heart. Physiol Genomics,2005,23:79-88.
  • 10Chen WJ,Chen HW,Yu SL,et al. Gene expression profiles in hypoxic preconditioning using eDNA microarry analysis: altered expression of an angiogenic factor,carcinoembryonie antigen-related cell adhesion molecule 1. Shock, 2005,24 : 124- 131.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部